Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | ERN1 | O75460 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21404724 | 1.00 | THRB (0.50) | THRBTSHRLMNASMN1; SMN2ACHE | |
| SCHEMBL586950 | 0.92 | THRB (0.42) | THRBTSHRLMNASMN1; SMN2ACHE | |
| SCHEMBL21055715 | 0.90 | THRB (0.41) | THRBTSHRACHEALDH1A1HRH4 | |
| SCHEMBL22035555 | 0.88 | THRB (0.59) | THRBTSHRLMNASMN1; SMN2ACHE | |
| SCHEMBL21404638 | 0.87 | THRB (0.50) | THRBTSHRACHEHRH4HRH3 | |
| SCHEMBL13872027 | 0.86 | THRB (0.58) | THRBTSHRLMNASMN1; SMN2ACHE | |
| SCHEMBL2407776 | 0.86 | THRB (0.58) | THRBTSHRLMNASMN1; SMN2ACHE | |
| SCHEMBL28282736 | 0.86 | THRB (0.61) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL21404692 | 0.85 | TSHR (0.47) | THRBTSHRACHEHRH4HRH3 | |
| SCHEMBL21404664 | 0.85 | TSHR (0.47) | THRBTSHRACHEHRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152045-B2 | Silane coupling compounds and medical and/or dental curable compositions comprising the same | KABUSHIKI KAISHA SHOFU (JP) | 2024-11-26 | — | — | US | disclosed |
| US-20210122770-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | KABUSHIKI KAISHA SHOFU (JP) | 2021-04-29 | — | — | US | disclosed |
| US-10975229-B2 | Silane coupling compounds and medical and/or dental curable compositions comprising the same | KABUSHIKI KAISHA SHOFU (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20190300552-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | KABUSHIKI KAISHA SHOFU (JP) | 2019-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210122770-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | SMCHD1, CAD, EPM2A | THRB 3383/4885TSHR 2902/4885LMNA 1474/4885 |
| US-10975229-B2 | Silane coupling compounds and medical and/or dental curable compositions comprising the same | SMCHD1, CAD, EPM2A | THRB 3383/4885TSHR 2902/4885LMNA 1474/4885 |
| US-12152045-B2 | Silane coupling compounds and medical and/or dental curable compositions comprising the same | SMCHD1, CAD, EPM2A | THRB 3383/4885TSHR 2902/4885LMNA 1474/4885 |
| US-20190300552-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | SMCHD1, CAD, EPM2A | THRB 3383/4885TSHR 2902/4885LMNA 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.